Advocacy group urges orphan status for multidrug-resistant infections

03/8/2012 | Reuters

The Infectious Diseases Society of America is urging the FDA to grant orphan-disease status to drug-resistant bacterial infections, offering drugmakers marketing rights, tax credits and other incentives and paving the way for faster approval of drugs to combat the diseases.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care